Oligodendroglial Tumor — Trials

Oligodendroglial Tumor — Trials · CancerIndex

Clinical trials

Registered studies

188 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 51–55 of 55 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00994500	Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma	completed	Phase 1	20	National Cancer Institute (NCI)NIH	1	Jul 2, 2013	clinicaltrials
NCT01076530	Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors	completed	Phase 1	27	National Cancer Institute (NCI)NIH	2	May 3, 2013